Liver Transplantation for Pediatric Liver Cancer
- PMID: 32204368
- PMCID: PMC7140094
- DOI: 10.3390/cancers12030720
Liver Transplantation for Pediatric Liver Cancer
Abstract
Unresectable hepatocellular carcinoma (HCC) was first removed successfully with total hepatectomy and liver transplantation (LT) in a child over five decades ago. Since then, children with unresectable liver cancer have benefitted greatly from LT and a confluence of several equally important endeavors. Regional and trans-continental collaborations have accelerated the development and standardization of chemotherapy regimens, which provide disease control to enable LT, and also serve as a test of unresectability. In the process, tumor histology, imaging protocols, and tumor staging have also matured to better assess response and LT candidacy. Significant trends include a steady increase in the incidence of and use of LT for hepatoblastoma, and a significant improvement in survival after LT for HCC with each decade. Although LT is curative for most unresectable primary liver sarcomas, such as embryonal sarcoma, the malignant rhabdoid tumor appears relapse-prone despite chemotherapy and LT. Pediatric liver tumors remain rare, and diagnostic uncertainty in some settings can potentially delay treatment or lead to the selection of less effective chemotherapy. We review the current knowledge relevant to diagnosis, LT candidacy, and post-transplant outcomes for these tumors, emphasizing recent observations made from large registries or larger series.
Keywords: PRE-TEXT; chemotherapy; hepatoblastoma; hepatocellular carcinoma; histopathology; liver cancer; liver sarcoma; liver transplantation; neuroendocrine tumor; pediatric.
Conflict of interest statement
The authors declare no conflict of interest. SRTR Disclaimer: This review used some data from the Scientific Registry of Transplant Recipients (SRTR). The SRTR data system includes data on all donor, wait-listed candidates, and transplant recipients in the US, submitted by the members of the Organ Procurement and Transplantation Network (OPTN). The Health Resources and Services Administration (HRSA), US Department of Health and Human Services provides oversight to the activities of the OPTN and SRTR contractors. The SRTR data reported here have been supplied by the Minneapolis Medical Research Foundation (MMRF) as the contractor for the Scientific Registry of Transplant Recipients (SRTR). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy of or interpretation by the SRTR or the US Government.
Figures





Similar articles
-
Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).Liver Transpl. 2017 Dec;23(12):1577-1588. doi: 10.1002/lt.24847. Liver Transpl. 2017. PMID: 28834194 Free PMC article.
-
Assessment of Survival of Pediatric Patients With Hepatoblastoma Who Received Chemotherapy Following Liver Transplant or Liver Resection.JAMA Netw Open. 2019 Oct 2;2(10):e1912676. doi: 10.1001/jamanetworkopen.2019.12676. JAMA Netw Open. 2019. PMID: 31584686 Free PMC article.
-
Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma.Pediatr Transplant. 2018 Dec;22(8):e13305. doi: 10.1111/petr.13305. Epub 2018 Oct 19. Pediatr Transplant. 2018. PMID: 30341782
-
Hepatocellular carcinoma in children: hepatic resection and liver transplantation.Transl Gastroenterol Hepatol. 2018 Sep 10;3:59. doi: 10.21037/tgh.2018.09.05. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 30363724 Free PMC article. Review.
-
Liver transplantation for unresectable pancreatic neuroendocrine tumors with liver metastases in an era of transplant oncology.Gland Surg. 2018 Feb;7(1):42-46. doi: 10.21037/gs.2017.12.11. Gland Surg. 2018. PMID: 29629319 Free PMC article. Review.
Cited by
-
Living donor liver transplantation in an infant patient with progressive familial intrahepatic cholestasis along with hepatocellular carcinoma: a case report.Korean J Transplant. 2022 Mar 31;36(1):73-78. doi: 10.4285/kjt.21.0007. Korean J Transplant. 2022. PMID: 35769428 Free PMC article.
-
Outcomes following liver transplantation in young infants: Data from the SPLIT registry.Am J Transplant. 2021 Mar;21(3):1113-1127. doi: 10.1111/ajt.16236. Epub 2020 Sep 5. Am J Transplant. 2021. PMID: 32767649 Free PMC article.
-
Incidence trends and predictive model of hepatic malignant tumors in children: a population-based study.Am J Transl Res. 2022 Oct 15;14(10):7268-7289. eCollection 2022. Am J Transl Res. 2022. PMID: 36398244 Free PMC article.
-
Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA.Cell Mol Gastroenterol Hepatol. 2021;12(2):465-487. doi: 10.1016/j.jcmgh.2021.02.010. Epub 2021 Mar 2. Cell Mol Gastroenterol Hepatol. 2021. PMID: 33667716 Free PMC article.
-
Competitive risk analysis of the therapeutic value of liver transplantation for liver cancer in children: A population-based study.Front Surg. 2022 Aug 31;9:938254. doi: 10.3389/fsurg.2022.938254. eCollection 2022. Front Surg. 2022. PMID: 36117822 Free PMC article.
References
-
- Demirleau N., Noureddine B., Vignes P., Prawerman A., Reziciner L., Larraud P., Louvier N. Attempted hepatic homograft. Mem. Acad. Chir. 1964;90:177–179. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources